Outspoken Oncology

David Fajgenbaum, MD, MBA, MSc, survivor of Castleman disease and author of "Chasing My Cure," discusses treating his own disease through experimental self-administered therapies, involvement in developing the first NCCN guidelines and FDA-approved drugs for Castleman disease, and how to effectively and systematically use off-label drugs for orphan diseases.

Matt Kalaycio, MD, Cleveland Clinic, simplifies initial therapy and monitoring decisions for CML, financial implications for patients treated with TKIs, and treatment choices dictated by payers for patients with specific characteristics.

To read more about our host Chadi Nabhan and access exclusive materials and information about guests, visit journalofclinicalpathways.com/podcasts/outspoken-oncology.

Journal of Clinical Pathways is the exclusive producer of the Outspoken Oncology podcast.

Matt Kalaycio, MD, Cleveland Clinic, simplifies initial therapy and monitoring decisions for CML, financial implications for patients treated with TKIs, and treatment choices dictated by payers for patients with specific characteristics.

To read more about our host Chadi Nabhan and access exclusive materials and information about guests, visit journalofclinicalpathways.com/podcasts/outspoken-oncology.

Journal of Clinical Pathways is the exclusive producer of the Outspoken Oncology podcast.

Carla Tardif, CEO of Family Reach, sits down with Chadi to discuss the personal expenses that patients with cancer and their families are burdened with aside from medical care as well as the ways in which Family Reach is offering financial support for these families.

Carla Tardif, CEO of Family Reach, sits down with Chadi to discuss the personal expenses that patients with cancer and their families are burdened with aside from medical care as well as the ways in which Family Reach is offering financial support for these families.

Anita Gruninger, RN and certified case manager, provides the often-forgotten perspective of a caregiver, including the emotional and financial toll a cancer diagnosis has on patients and their caregivers as well as the struggles of navigating the health care system.

Anita Gruninger, RN and certified case manager, provides the often-forgotten perspective of a caregiver, including the emotional and financial toll a cancer diagnosis has on patients and their caregivers as well as the struggles of navigating the health care system.

Toni Choueiri, MD, kidney cancer specialist at Dana-Farber Cancer Institute, discusses surgical considerations and multidisciplinary care for localized kidney cancer, adjuvant therapies largely falling short of expectations, and the plethora of frontline therapies available in metastatic disease.

Toni Choueiri, MD, kidney cancer specialist at Dana-Farber Cancer Institute, discusses surgical considerations and multidisciplinary care for localized kidney cancer, adjuvant therapies largely falling short of expectations, and the plethora of frontline therapies available in metastatic disease.

Aaron Gerds, MD, department of hematology and medical oncology, Cleveland Clinic, describes the benefits and pitfalls of Twitter as a platform for doctors to share their ideas and engage in the "ultimate peer-review process."